Open AccessAdministration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients
Author(s) -
Michael R. Marvin,
Cathy Droogan,
Deirdre Sawinski,
David J. Cohen,
Mark A. Hardy
Publication year - 2003
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000047313.06232.d3
Subject(s) - medicine , thymoglobulin , premedication , ambulatory , globulin , complication , incidence (geometry) , hemodialysis , surgery , renal transplant , heparin , anesthesia , kidney transplantation , transplantation , physics , optics
Antilymphocyte globulins have been used for the treatment and prevention of acute rejection in renal-allograft recipients. Thymoglobulin, rabbit antithymocyte globulin (RATG), has been shown to be effective for these indications and has been used primarily on an inpatient basis because of the recommendation that it be administered through a central line.